ioGlutamatergic Neurons

Human-induced glutamatergic neurons

e001  |  Formerly known as ioNEURONS/glut

ioGlutamatergic Neurons have been reprogrammed from human induced pluripotent stem cells (iPSC) using our precise reprogramming technology: opti-ox™¹ (optimized inducible overexpression). Human stem cells, within days, convert into consistent, mature, functional glutamatergic neurons providing a high quality human model for the study of neurological activity and disease.

ioGlutamatergic Neurons consist mainly of glutamatergic neurons (>80%) characterised by the expression of the glutamate transporter genes VGLUT1 and VGLUT2. The minor remaining fraction of the neuronal population express marker genes of cholinergic neurons. A bulk RNA-seq analysis shows that ioGlutamatergic Neurons have a rostral CNS identity and express the classical cortical marker genes FOXG1 and TBR1 (data not shown).

Ready-to-culture cells are suitable as models for research in cell-type specific biology, target validation and drug screening in pharmaceutical R&D, and toxicology testing.

¹ Pawlowski et al., Stem Cell Report 2017


Ready for experimentation within days
Highly characterised and defined
Early electrical signal
Easy culturing


Academic research
– Drug development
– Neurotoxicology
– High-throughput screening
– Genetic screening (e.g. CRISPR screening)
3D bioprinting

For more information please email:

Batch to batch reproducibility and homogeneity create a stable human model for excitatory neuronal activity and disease.

Ready for experimentation as early as 2 days post revival and form functional neuronal networks at 17 days.

Industrial scale quantities at a price point that allows the cells to be used from research to screening scale.

Cells arrive programmed to rapidly mature upon revival. One medium required in a two-step protocol.

ioGlutamatergic Neurons generated by NGN2-driven reprogramming of iPSCs using opti-ox™ technology

Video capturing the rapid morphological changes from iPSCs upon induction of NGN2 expression using opti-ox™ cellular reprogramming. 7 day time course.

Video capturing the rapid morphological changes from iPSCs upon induction of NGN2 expression using opti-ox™ cellular reprogramming. 7 day time course.

ioGlutamatergic Neurons express glutamatergic neuron-specific markers





Immunofluorescent staining on post-revival day 11 demonstrates homogenous expression of pan-neuronal proteins (MAP2 and TUBB3) and glutamatergic neuron-specific transporters (VGLUT1 and VGLUT2). Cells exhibit neurite outgrowth.

ioGlutamatergic Neurons after revival over the course of the first 11 days

Day 1 to 11 post-thawing; 400X magnification; scale bar: 100µm.

ioGlutamatergic Neurons display neuronal activity that matures over-time

neuronal activity

Examples of MaxOne high-resolution multi electrode array (MEA) recordings of ioGlutamatergic Neurons in BrainPhys™ media. The activity maps show firing rate (A), spike amplitude (B) and % of active electrodes (C). Results demonstrate a time-dependent increase of spontaneous activity during neuronal maturation from 2 to 3 weeks post-revival.

Iovino, M. et al., 2019, Charles River Laboratories.

ioGlutamatergic Neurons show good suitability for high-throughput screening in 384-well format plates

Cytotoxicity CellTiter-Glo®️ (CTG) and TR-FRET (HTRF®️) assays for AKT serine/threonine kinase 1 (AKT) and Huntingtin (HTT) proteins were performed on ioGlutamatergic Neurons in 384-well plates treated with tool compound (cmp) at day 9 post-revival. Compound titration results in a concentration response curve for all three assays (mean±sd of 2 replicates). CTG assay on ioGlutamatergic Neurons shows an excellent average signal/ background ratio and high suitability for HTS. HTRF® assays on ioGlutamatergic Neurons show lower signals but with low variability, and could therefore also provide a suitable platform for HTS.

Iovino, M. et al., 2019, Charles River Laboratories.

 Cells arrive ready to plate ioGlutamatergic Neurons vials of cells
ioGlutamatergic Neurons arrive ready to plate

ioGlutamatergic Neurons are delivered in a cryopreserved format and are programmed to rapidly mature upon revival in the recommended media. The protocol for the generation of these cells is a three-phase process: 1. Induction (carried out at 2. Stabilization for 4 days with Dox 3. Maintenance during which the neurons mature.

Cost effective and flexible

cost effective ioGlutamatergic Neurons

ioGlutamatergic Neurons are compatible with plates ranging from 6 to 384 wells and are available in two vial sizes, tailored to suit your experimental needs with minimal waste. Recommended seeding density for ioGlutamatergic Neurons is 30,000 cells/cm2, compared to up to 250,000 cells/cm2 for other available products on the market. One Small vial can plate a minimum of 0.5 x 24-well plate, 0.75 x 96-well plate, or 1 x 384-well plate. One Large vial can plate a minimum of 1 x 24-well plate, 1.5 x 96-well plate, or 2 x 384-well plates.

Product Information

Catalogue number: e001 Manufacture site: United Kingdom Sizes: Small & Large Product use: These cells are for research use only Storage: Upon receiving, directly and immediately transfer the cells from dry ice to liquid nitrogen and keep the cells in liquid nitrogen until they are needed for experiments Shipping info: Dry Ice Note: Limited Use License | Statement of Use

Download resources

Other products